(This is associative evidence and may reflect confounding by indication, surveillance patterns, and glycaemic differences.) For post-marketing pharmacovigilance, FAERS-based analyses of semaglutide identify multiple safety signals (e.g., gastrointestinal obstruction-related terms, dehydration/volume depletion in some GLP-1RA analyses), but vulvovaginal dryness/infection/discharge/pain are not prominent as labelled risks in the major semaglutide FAERS disproportionality paper retrieved here
Distribution and Metabolism Orforglipron exhibits distribution characteristics typical of lipophilic small molecules with moderate plasma protein binding
Some studies suggest it's as short as 1-2 minutes, while others place it closer to 5-10 minutes
PlexusDx supports precision-wellness approaches by connecting clinical evidence with individual biomarker context, helping you engage with your provider on personalized treatment decisions
For the data-dependent MS/MS scans, the resolution was set at 17500, isolation 2 m/z , with a normalized collision energy of 28 (arbitrary unit)
PMID: 38544798